AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Nice puts Actimize up for sale at a $1.5-2 billion price tag
3
Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers
4
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
5
Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ
More news

Pharmaceutical

12 stories about Pharmaceutical
הפגנה עובדי טבע קריית שמונה

Kibbutz-Owned Food Manufacturer Maabarot Bids for Teva’s North Israel Facility

16.10.18|Golan Hazani
Last week, Calcalist reported that Teva was nearing the sale of its Kiryat Shmona facility to German pharmaceutical device company B. Braun
הפגנה עובדי טבע קריית שמונה

Teva Nearing Sale of Israeli Manufacturing Plant

09.10.18|Golan Hazani
The pharmaceutical company is negotiating the sale of a manufacturing facility located in the town Kiryat Shmona in the north of Israel
הפגנה מפגינים פיטורים טבע אשדוד

Teva Outsources Manufacturing in Anticipation of Israeli Plant Closure

27.08.18|Golan Hazani
The debt-laden drugmaker announced an aggressive reorganization plan in December, consisting of wide-spread asset divestments and layoffs, including in its home country of Israel
עלה קנאביס

Israeli Cannabis Startup InnoCan Pharma Raises $800,000 Via Crowdfunding

27.08.18|Lilach Baumer
InnoCan develops medication for psoriasis and muscle and joint pains. Its management team includes former senior executives at Teva and Pfizer
ענת כהן-דייג מנכ"לית קומפיוג'ן

AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen

03.04.18|Lilach Baumer
The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen
מנכ"ל טבע גנריקה סיגורדור סיגי אולפסון

Drugmaker Hikma Appoints Former Teva Executive as CEO

20.02.18|Asaf Shalev
The appointment of Sigurdur Olafsson comes as Hikma has been struggling to bolster the performance of its generic drugs unit
רחוב יפו רכבת קלה ירושלים

Merck Group Inaugurates Jerusalem Innovation Lab

07.02.18|Lilach Baumer
The new lab is located at Merck subsidiary Qlight Nanotech, acquired by the pharmaceutical company in 2015
תל אביב מבט על מ למעלה

Danish Leo Pharma is Launching an Innovation Lab in Israel

04.02.18|Lilach Baumer
Established in 2015, Leo Pharma’s innovation lab currently operates in Copenhagen, London, Paris, and Toronto, developing digital health solutions
מטה טבע פתח תקווה

Following U.S. Bribe Settlement, Teva to Pay $22 Million Fine in Israel

15.01.18|Tomer Ganon
Yesterday, the Israeli state attorney settled a suit against the company. In 2016, Teva agreed to pay $519 million to settle anti-bribery violations in the U.S.
עובדי מפעל טבע נתניה

Moody’s Downgrades Teva Bond Rating to “Junk”

14.01.18|Lilach Baumer
The credit rating agency is following is the steps of Fitch, which did the same in November. Of the “big three,” only S&P Global still rates Teva as investment grade
default image

Pontifax Raises a $240 Million Fifth Fund

01.01.18|Meir Orbach
Life sciences-focused venture capital firm Pontifax is expected to invest most of the new fund in the pharmaceutical industry
מנכ"ל טבע החדש קור שולץ

Teva Might Have Been Better Off as a Smaller Company, new CEO Says

17.12.17|Dror Reich
The generic drugs powerhouse is now carrying a $34.7 billion debt—a result of a $40.5 acquisition of Actavis. New CEO Kåre Schultz presented a detailed restructuring plan on Thursday
Previous Articles